Group One Trading’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Group One Trading’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Hold	0	–	–	–	5578
2018 Q1	–	Sell	-4	Closed	-$1.99K	–	5424
2017 Q4	$2K	Buy	+4	New	+$2.64K	﹤0.01%	4704
2016 Q4	–	Sell	-12	Closed	-$12K	–	4937
2016 Q3	$12K	Buy	12 +10	+500%	+$12.6K	﹤0.01%	3997
2016 Q2	$2K	Sell	2 -4	-67%	-$5.14K	﹤0.01%	4452
2016 Q1	$7K	Buy	6 +2	+50%	+$2.31K	﹤0.01%	4129
2015 Q4	$5K	Sell	4 -5	-56%	-$6.52K	﹤0.01%	4382
2015 Q3	$13K	Buy	9 +6	+200%	+$11.6K	﹤0.01%	4211
2015 Q2	$7K	Buy	+3	New	+$9.41K	﹤0.01%	4410
2015 Q1	–	Sell	-2	Closed	-$6.4K	–	5305
2014 Q4	$6K	Sell	2 -7	-78%	-$24.8K	﹤0.01%	4424
2014 Q3	$34K	Sell	9 -1	-10%	-$3.89K	﹤0.01%	3800
2014 Q2	$40K	Buy	10 +7	+233%	+$26.3K	﹤0.01%	3691
2014 Q1	$13K	Sell	3 -10	-77%	-$44.6K	﹤0.01%	4484
2013 Q4	$50K	Sell	13 -5	-28%	-$18.9K	﹤0.01%	3622
2013 Q3	$70K	Buy	+18	New	+$135K	﹤0.01%	3305

Other funds holding FRTX

PCM

Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MFG

Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

NFG

Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading's FRTX Position: Q2 2018 in Review

Group One Trading held its Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) position steady in Q2 2018 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5578.

Group One Trading first reported a position in FRTX in Q3 2013 and has held it in 13 quarters since. The position peaked at $70K in Q3 2013. 28 funds tracked by Wall St. Rank hold FRTX as of Q2 2018.

Group One Trading held 0 shares of Fresh Tracks Therapeutics, Inc. Common Stock worth $0 as of Q2 2018.
Group One Trading left its Fresh Tracks Therapeutics, Inc. Common Stock share count unchanged in Q2 2018.
Fresh Tracks Therapeutics, Inc. Common Stock made up ﹤0.01% of Group One Trading's portfolio in Q2 2018, its #5578 holding.
Group One Trading first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2013 and has held it in 13 quarters since.
Group One Trading's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $70K in Q3 2013.
28 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2018.

Based on Group One Trading's 13F filing for Q2 2018, filed 14 Aug 2018.